KRT88P and hepatitis B virus infection: A recent study showed that anti-HBc levels were associated with ALT levels and could distinguish active hepatitis B patients from inactive carriers (15), meaning that anti-HBc might also be a biomarker of inflammation or fibrosis for HBeAg positive patients (16, 17).